Back
Cartesian Therapeutics Stock Price Chart
Former Zillow execs target $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
29
RNAC
Cartesian Therapeutics
Last Price:
$9.91
Seasonality Move:
13.04%
7 Day Trial
ALL ACCESS PASS
$
7
Missed investing in Uber? Don't Miss Mode.
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RNAC is experiencing slight selling pressure.
Cartesian Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.31 | Sell |
| 20-day SMA: | 11.42 | Sell |
| 50-day SMA: | 13.54 | Sell |
| 200-day SMA: | 17.02 | Sell |
| 8-day EMA: | 10.92 | Sell |
| 20-day EMA: | 11.53 | Sell |
| 50-day EMA: | 13.25 | Sell |
| 200-day EMA: | 16.9 | Sell |
Cartesian Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.71 | Sell |
| Relative Strength Index (14 RSI): | 36.96 | Sell |
| Chaikin Money Flow: | -51535 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.21 - 12.17) | Sell |
| Bollinger Bands (100): | (12.82 - 19.48) | Sell |
Cartesian Therapeutics Technical Analysis
| Apr 28 | Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 28 | 29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Cartesian Therapeutics Stock
Is Cartesian Therapeutics Stock a Buy?
-
Cartesian Therapeutics share price is 9.90 while RNAC 8-day simple moving average is 11.31, which is a Sell signal.
-
The stock price of RNAC is 9.90 while Cartesian Therapeutics 20-day SMA is 11.42, which makes it a Sell.
-
Cartesian Therapeutics 50-day simple moving average is 13.54 while RNAC share price is 9.90, making it a Sell technically.
-
RNAC stock price is 9.90 and Cartesian Therapeutics 200-day simple moving average is 17.02, creating a Sell signal.
RNAC Technical Analysis vs Fundamental Analysis
Sell
29
Cartesian Therapeutics (RNAC)
is a Sell
Is Cartesian Therapeutics a Buy or a Sell?
-
Cartesian Therapeutics stock is rated a SellThe current Cartesian Therapeutics [RNAC] share price is $9.90. The Score for RNAC is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
Cartesian Therapeutics Stock Info
Market Cap:
256.8M
Price in USD:
9.90
Share Volume:
215.9K
Cartesian Therapeutics 52-Week Range
52-Week High:
41.87
52-Week Low:
8.85
Sell
29
Cartesian Therapeutics (RNAC)
is a Sell
Cartesian Therapeutics Share Price Forecast
-
What is the Cartesian Therapeutics stock price today?The Cartesian Therapeutics stock price is 9.90 USD today.
-
Will RNAC stock go up or go down?Cartesian Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Cartesian Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cartesian Therapeutics is overvalued.
Is Cartesian Therapeutics Stock a Buy?
-
Cartesian Therapeutics share price is 9.90 while RNAC 8-day exponential moving average is 10.92, which is a Sell signal.
-
The stock price of RNAC is 9.90 while Cartesian Therapeutics 20-day EMA is 11.53, which makes it a Sell.
-
Cartesian Therapeutics 50-day exponential moving average is 13.25 while RNAC share price is 9.90, making it a Sell technically.
-
RNAC stock price is 9.90 and Cartesian Therapeutics 200-day simple moving average is 16.90, creating a Sell signal.
Fundamental Analysis of Cartesian Therapeutics
Is Cartesian Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.08 per share, and an increase next year of $1.95 per share.
Technical Analysis of Cartesian Therapeutics
Should I short Cartesian Therapeutics stock?
-
RNAC Moving Average Covergence Divergence (MACD) indicator is -0.71, suggesting Cartesian Therapeutics is a Sell
-
Cartesian Therapeutics Relative Strength Index (RSI) is 36.96, which suggest Cartesian Therapeutics is oversold
-
The Bollinger Bands (25) for Cartesian Therapeutics is (10.21 - 12.17), which suggest Cartesian Therapeutics is a Sell
-
The Bollinger Bands (100) for Cartesian Therapeutics is (12.82 - 19.48), which suggest Cartesian Therapeutics is a Sell
* Cartesian Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.